At VivaTech 2026, Europe's largest technology event, medtech startup Beams was awarded the title of Best Pitch 2026 at the INPI France Pitch Contest, organized in partnership with the World Intellectual Property Organization - WIPO and HEC Paris. This distinction rewards the clarity of Beams' vision and the strength of an innovation designed to transform surgical oncology.

The Pitch Contest brought together some of the most promising deeptech and medtech ventures, each presenting a technology backed by strong intellectual property. Being recognized in this setting. At the crossroads of innovation, entrepreneurship, and IP excellence, underscores both the scientific foundations of Beams and the growing relevance of its mission for patients and surgeons alike.

At the heart of this recognition is TRIOP, Beams' miniaturized intraoperative probe that provides surgeons with real-time guidance during cancer surgery. By detecting residual tumor tissue directly in the operating field, TRIOP helps surgeons perform more complete resections, with the goal of reducing reoperations and improving outcomes for patients undergoing oncological surgery.

Winning Best Pitch at an event organized by INPI, WIPO, and HEC Paris carries particular significance for a deeptech company. It highlights not only the quality of the technology, but also the importance of protecting and communicating innovation, a cornerstone of Beams' strategy as it advances toward clinical adoption and European market access.

This award adds to a series of recognitions that reflect Beams' trajectory in French and European medtech: a startup born from scientific excellence, driven by a clear purpose to redefine precision in surgical oncology and improve the lives of cancer patients worldwide.

‍